Fly News Breaks for August 8, 2019
Aug 8, 2019 | 07:24 EDT
Canaccord analyst Arlinda Lee raised her price target on Xencor to $52 from $45 citing its commercial product Xtend which is already generating sales, multiple partnered programs, and wholly owned programs progressing through the clinic. Lee reiterated her Buy rating on Xencor shares.
News For XNCR From the Last 2 Days